PubHawk
May 2016 PMID 27160842

Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.

Nathan J Coombs, Joel M Coombs, Uma J Vaidya, Julian Singer, Max Bulsara, Jeffrey S Tobias, Frederik Wenz, David J Joseph, Douglas A Brown, Richard Rainsbury, Tim Davidson, Douglas J A Adamson, Samuele Massarut, David Morgan, Ingrid Potyka

Full text PDF Download social card

Mentions

13
Peak: 2 in May 2016
across 5 sources since May 2016

Extended reach

2,128
potential audience

Total likes

7

Video views

1,043

Mentions per month

May 2016 – Nov 2021

Where it's discussed

  • News4 articles
  • Blogs4 articles
  • YouTube2 videos
  • Facebook2 posts
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussion emphasizes the environmental and logistical advantages of TARGIT intraoperative radiotherapy, citing specific figures like saving 8 million km of travel and reducing CO2 emissions, which highlights the perceived high impact of the procedure. The tone and focus on quantifiable benefits demonstrate a strong agreement with the article’s framing of TARGIT’s benefits, though it mostly concentrates on logistical and environmental aspects rather than clinical outcomes.

AgreementStrong agreement

The discussion strongly supports the environmental and logistical benefits highlighted in the article, emphasizing the significant savings in travel and carbon emissions.

InterestModerate interest

The post indicates moderate interest, focusing on concrete benefits like miles of travel saved and environmental impact, but lacks broader critical analysis.

EngagementModerate engagement

The discussion reflects some level of engagement through quantifying benefits, yet remains mostly summary without deep exploration of clinical implications.

ImpactHigh impact

Given the emphasis on substantial environmental savings and potential benefits for patients, the discussion perceives the study as having a high societal and environmental impact.

Abstract in brief

  • TARGIT intraoperative radiotherapy offers similar breast cancer control as traditional external beam radiotherapy (EBRT), especially when given during lumpectomy, and has been studied in UK clinical trials including the TARGITA trial.
  • Patients receiving TARGIT travelled significantly shorter distances, with lower CO2 emissions and less travel time compared to those undergoing multiple sessions of EBRT, leading to environmental and logistical benefits.
  • The study highlights that TARGIT reduces overall travel distances, time, and carbon footprint for breast cancer patients, particularly benefiting those in semi-rural areas by minimizing their need for long journeys to treatment centers.
Read the full abstract

Top posts

Most liked on X and Bluesky
Prof Jayant Vaidya
@jsvaidya · X

#COP26 TARGIT-IORT during lumpectomy for breast cancer, in addition to benefiting patients, would save 5 million miles (8 million km) of travel, 170000 woman-hours & 1200 tonnes of CO2 (a forest of 100 hectares) annually in the UK https://t.co/KPVxanvPHH https://t.co/ODieBfjM1i

Nov 2, 2021 · 4 likes · 1 share · 1,084 followers View post →

All mentions

Prof Jayant Vaidya
@jsvaidya · X

#COP26 TARGIT-IORT during lumpectomy for breast cancer, in addition to benefiting patients, would save 5 million miles (8 million km) of travel, 170000 woman-hours & 1200 tonnes of CO2 (a forest of 100 hectares) annually in the UK https://t.co/KPVxanvPHH https://t.co/ODieBfjM1i

Nov 2, 2021 · 4 likes · 1 share · 1,084 followers View post →